company-logo

CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette Guerin (BCG) therapy, the current standard-of-care for high-risk NMIBC.

CG Oncology Dividend Announcement

CG Oncology does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on CG Oncology dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

CG Oncology Dividend History

CG Oncology Dividend Yield

CG Oncology current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing CG Oncology stock? Use our calculator to estimate your expected dividend yield:

CG Oncology Financial Ratios

P/E ratio-31.50
PEG ratio-0.32
P/B ratio4.25
ROE-15.70%
Payout ratio0.00%
Current ratio35.32
Quick ratio35.32
Cash Ratio2.78

CG Oncology Dividend FAQ

Does CG Oncology stock pay dividends?
CG Oncology does not currently pay dividends to its shareholders.
Has CG Oncology ever paid a dividend?
No, CG Oncology has no a history of paying dividends to its shareholders. CG Oncology is not known for its dividend payments.
Why doesn't CG Oncology pay dividends?
There are several potential reasons why CG Oncology would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will CG Oncology ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While CG Oncology has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is CG Oncology a dividend aristocrat?
CG Oncology is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is CG Oncology a dividend king?
CG Oncology is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is CG Oncology a dividend stock?
No, CG Oncology is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy CG Oncology stocks?
To buy CG Oncology you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy CG Oncology stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.